SYKStryker Corporation

$276.48
Latest close: a new 52-week lowSep 8, 2026what changed →

The financials

Stryker Corporation by the numbers

Stryker Corporation (SYK) reported revenue of $6.59B in Q2 2026 (quarter ended Jun 30, 2026), up 9.4% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $1.28B (19% of revenue). For the full year FY2025, revenue was $25.1B (+11% year on year) and net income $3.25B. Its largest product in Q2 2026 was Traumaand Extremities at $1.07B, 16% of the disclosed total, just ahead of Endoscopy at 15%.

Stryker Corporation income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$6.59B$6.02B+9.4%
Gross profit$4.50B$3.84B+17%
Operating income$1.66B$1.11B+49%
Net income$1.28B$884M+44%
Diluted EPS$3.30$2.29+44%
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Traumaand Extremities$1.07B16%
Endoscopy$1.00B15%
Instruments$1.00B15%
Ortho Tech$717M10%
Knees$693M10%
Neuro Cranial Instruments$681M9.9%
Orthopaedic Instruments$523M7.6%
Neurovascular$496M7.2%
Hips$479M6.9%
Other Orthopedics$194M2.8%
Enabling Technologies$28M0.4%
Spinal Implants$3.0M0.0%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q2 2026Total $6.89B (+7.8%)
Other Orthopedics grew +31% year on yearSpinal Implants -40% year on year
  • Trauma and Extremities$1.07BQoQ +3.6%year on year +12%
  • Endoscopy$1.00BQoQ +16%year on year +12%
  • Instruments$1.00BQoQ +9.0%year on year +9.3%
  • Ortho Tech$717.0MQoQ +11%year on year +10%
  • Knees$693.0MQoQ +3.4%year on year +8.3%
  • Neuro Cranial Instruments$681.0MQoQ +12%year on year +11%
  • Orthopaedic Instruments$523.0MQoQ +7.0%year on year +4.4%
  • Neurovascular$496.0MQoQ -4.1%year on year -0.40%
  • Hips$479.0MQoQ +4.1%year on year +2.8%
  • Other Orthopedics$194.0MQoQ +24%year on year +31%
  • Enabling Technologies$28.0MQoQ +7.7%year on year -18%
  • Spinal Implants$3.0MQoQ +50%year on year -40%
Segment sum = 105% of reported consolidated revenue · Latest source: 10-Q filed 2026-07-31, SEC EDGAR